GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Momenta Pharmaceuticals Inc (NAS:MNTA) » Definitions » E10

Momenta Pharmaceuticals (Momenta Pharmaceuticals) E10 : $-0.91 (As of Jun. 2020)


View and export this data going back to 2004. Start your Free Trial

What is Momenta Pharmaceuticals E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Momenta Pharmaceuticals's adjusted earnings per share data for the three months ended in Jun. 2020 was $-0.480. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-0.91 for the trailing ten years ended in Jun. 2020.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-05-05), Momenta Pharmaceuticals's current stock price is $52.48. Momenta Pharmaceuticals's E10 for the quarter that ended in Jun. 2020 was $-0.91. Momenta Pharmaceuticals's Shiller PE Ratio of today is .


Momenta Pharmaceuticals E10 Historical Data

The historical data trend for Momenta Pharmaceuticals's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Momenta Pharmaceuticals E10 Chart

Momenta Pharmaceuticals Annual Data
Trend Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.95 -0.84 -0.75 -0.79 -0.91

Momenta Pharmaceuticals Quarterly Data
Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.86 -0.86 -0.91 -0.90 -0.91

Competitive Comparison of Momenta Pharmaceuticals's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Momenta Pharmaceuticals's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Momenta Pharmaceuticals's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Momenta Pharmaceuticals's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Momenta Pharmaceuticals's Shiller PE Ratio falls into.



Momenta Pharmaceuticals E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Momenta Pharmaceuticals's adjusted earnings per share data for the three months ended in Jun. 2020 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2020 (Change)*Current CPI (Jun. 2020)
=-0.48/108.7673*108.7673
=-0.480

Current CPI (Jun. 2020) = 108.7673.

Momenta Pharmaceuticals Quarterly Data

per share eps CPI Adj_EPS
201009 0.700 92.162 0.826
201012 0.790 92.474 0.929
201103 1.130 94.283 1.304
201106 1.260 95.235 1.439
201109 1.180 95.727 1.341
201112 -0.030 95.213 -0.034
201203 -0.100 96.783 -0.112
201206 -0.200 96.819 -0.225
201209 -0.510 97.633 -0.568
201212 -0.350 96.871 -0.393
201303 -0.480 98.209 -0.532
201306 -0.570 98.518 -0.629
201309 -0.500 98.790 -0.550
201312 -0.590 98.326 -0.653
201403 -0.530 99.695 -0.578
201406 -0.510 100.560 -0.552
201409 -0.560 100.428 -0.607
201412 -0.310 99.070 -0.340
201503 -0.400 99.621 -0.437
201506 -0.040 100.684 -0.043
201509 -0.442 100.392 -0.479
201512 -0.430 99.792 -0.469
201603 -0.350 100.470 -0.379
201606 -0.310 101.688 -0.332
201609 -0.260 101.861 -0.278
201612 0.600 101.863 0.641
201703 -0.460 102.862 -0.486
201706 -0.500 103.349 -0.526
201709 -0.440 104.136 -0.460
201712 0.180 104.011 0.188
201803 -0.630 105.290 -0.651
201806 -0.910 106.317 -0.931
201809 -0.650 106.507 -0.664
201812 -0.100 105.998 -0.103
201903 -0.460 107.251 -0.467
201906 -1.160 108.070 -1.167
201909 -0.450 108.329 -0.452
201912 -0.850 108.420 -0.853
202003 -0.340 108.902 -0.340
202006 -0.480 108.767 -0.480

Add all the adjusted EPS together and divide 10 will get our e10.


Momenta Pharmaceuticals  (NAS:MNTA) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Momenta Pharmaceuticals E10 Related Terms

Thank you for viewing the detailed overview of Momenta Pharmaceuticals's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Momenta Pharmaceuticals (Momenta Pharmaceuticals) Business Description

Traded in Other Exchanges
N/A
Address
301 Binney Street, Cambridge, MA, USA, 02142
Momenta is a biotechnology company focused on the characterization and development of innovative drugs in autoimmune diseases. Its legacy business includes complex generic versions of MS drug Copaxone and anticoagulant Lovenox, and it receives royalties for these products through a partnership with Novartis. While a biosimilar version of Eylea is in the pipeline, Momenta terminated future development in generics/biosimilars in 2018. Several innovative drugs, including nipocalimab, M254, and M230, are in development to treat rare autoimmune diseases.
Executives
Bruce Downey director
Alejandra Carvajal officer: Chief Legal Officer C/O CERULEAN PHARMA INC., 840 MEMORIAL DRIVE, 5TH FLOOR, CAMBRIDGE MA 02139
Jose-carlos Gutierrez-ramos director C/O MOMENTA PHARMACEUTICALS, INC., 675 WEST KENDALL STREET, CAMBRIDGE MA 02142
Georges Gemayel director 550 HILLS DRIVE, BEDMINSTER NJ 07921
Elizabeth Stoner director C/O MOMENTA PHARMACEUTICALS, INC. 675 WEST KENDALL STREET CAMBRIDGE MA 02142
Santiago Arroyo officer: SVP, Chief Medical Officer C/O MOMENTA PHARMACEUTICALS, INC., 675 WEST KENDALL STREET, CAMBRIDGE MA 02142
Young Kwon officer: Chief Financial & Bus. Officer C/O MOMENTA PHARMACEUTICALS INC., 675 WEST KENDALL STREET, CAMBRIDGE MA 02142
Ian Fier officer: Chief Mfg and Program Officer C/O MOMENTA PHARMACEUTICALS, INC. 301 BINNEY STREET CAMBRIDGE MA 02142
Steven C Gilman director 110 HARTWELL AVENUE, LEXINGTON MA 02421
Jo Ann Beltramello officer: Chief HR and Inf. Officer C/O MOMENTA PHARMACEUTICALS, INC. 301 BINNEY STREET CAMBRIDGE MA 02142
Jane F Barlow director 6800 BROKEN SOUND PARKWAY NW, 3RD FLOOR, BOCA RATON FL 33487
Anthony M. Manning officer: Chief Scientific Officer C/O PALATIN TECHNOLOGIES, INC., 4B CEDAR BROOK DRIVE, CRANBURY NJ 08512
Donna Roy Grogan director 1133 OLD QUEEN ANNE ROAD, CHATHAM MA 02633
Agnieszka Cieplinska officer: Chief Accounting Officer (PAO) C/O MOMENTA PHARMACEUTICALS, INC. 301 BINNEY STREET CAMBRIDGE MA 02142
Craig A Wheeler director, officer: President & CEO